Nutriband (NTRB)
(Delayed Data from NSDQ)
$7.17 USD
+0.04 (0.56%)
Updated Aug 8, 2025 04:00 PM ET
After-Market: $7.29 +0.12 (1.67%) 7:58 PM ET
3-Hold of 5 3
D Value B Growth A Momentum C VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
NTRB 7.17 +0.04(0.56%)
Will NTRB be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for NTRB based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for NTRB
Aclaris Therapeutics (ACRS) Reports Q2 Loss, Beats Revenue Estimates
Nutriband Inc. (NTRB) Reports Q1 Loss, Misses Revenue Estimates
NTRB: What are Zacks experts saying now?
Zacks Private Portfolio Services
Other News for NTRB
12 Health Care Stocks Moving In Friday's Pre-Market Session
Nutriband announces FDA granted Type C Meeting for AVERSA FENTANYL
Nutriband (NTRB) Announces Dividend Details for Preferred Stock | NTRB Stock News
Nutriband Confirms Record and Pay date for 25% Preferred Stock Dividend as it Targets Filing ...